The DOI matches its Crossref record.
B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells.
Abstract
The human B cell restricted activation antigen B7 identifies an in vivo primed subpopulation of B cells that demonstrate an accelerated response to triggers of B cell activation and proliferation. The cDNA encoding B7 was molecularly cloned by cDNA expression. The identity of the B7 cDNA was confirmed by indirect immunofluorescence and immunoprecipitation of a 44/54-kDa protein from B7 transfected COS cells. The sequence of the B7 polypeptide predicts a type I membrane protein of 262 amino acids with eight potential N-linked glycosylation sites in the extracellular region and a short, highly positively charged cytoplasmic tail. The extracellular region is homologous to the Ig gene superfamily and consists of two contiguous Ig-like domains. The first Ig domain has the characteristics of a variable domain and the second that of a constant region domain. B7 mRNA was detected only on anti-Ig activated B lymphocytes and not in other hematopoietic cells. After in vitro activation of B cells with anti-Ig, B7 mRNA was maximally expressed between 4 and 12 h with four RNA transcripts of 1.7, 2.9, 4.2, and 10 kb. The 2.9-kb mRNA predominated in in vitro-activated B cells whereas the 1.7-kb mRNA was most abundant in tumor cells of B cell origin. B7 expression was confined to several histologically defined subgroups of B cell malignancies. The majority of non-Hodgkin's lymphomas were B7+ whereas the B cell leukemias and circulating non-Hodgkin's lymphomas were generally negative. These results demonstrate that the B7 gene encodes a unique molecule belonging to the Ig superfamily and that B7 expression is limited to normal activated B cells and noncirculating B cell malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
Butte, M. J., Keir, M. E., Phamduy, T. B., Sharpe, A. H., & Freeman, G. J. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.016 · Cited by 1,732
Self-citationCTLA-4 is a second receptor for the B cell activation antigen B7.
Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.561 · Cited by 1,685
Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.721 · Cited by 1,127
Chen, L., Ashe, S., Brady, W. A., Hellström, I., Hellström, K. E., Ledbetter, J. A., McGowan, P., & Linsley, P. S. (1992) · Cell · doi:10.1016/s0092-8674(05)80059-5 · Cited by 1,050
Linsley, P. S., Greene, J. L., Brady, W., Bajorath, J., Ledbetter, J. A., & Peach, R. (1994) · Immunity · doi:10.1016/s1074-7613(94)80021-9 · Cited by 980
B70 antigen is a second ligand for CTLA-4 and CD28
Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J. H., Lanier, L. L., & Somoza, C. (1993) · Nature · doi:10.1038/366076a0 · Cited by 909
Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation
Freeman, G. J., Gribben, J. G., Boussiotis, V. A., Ng, J. W., Restivo, V. A., Lombard, L. A., Gray, G. S., & Nadler, L. M. (1993) · Science · doi:10.1126/science.7694363 · Cited by 902
Self-citationT-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.
Linsley, P. S., Clark, E. A., & Ledbetter, J. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5031 · Cited by 747
Role of the CD28 receptor in T-cell activation
June, C. H., Ledbetter, J. A., Linsley, P. S., & Thompson, C. B. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90085-n · Cited by 676
Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.
Hathcock, K. S., Laszlo, G., Pucillo, C., Linsley, P., & Hodes, R. J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.631 · Cited by 669
How B and T cells talk to each other
Clark, E. A., & Ledbetter, J. A. (1994) · Nature · doi:10.1038/367425a0 · Cited by 641
Lenschow, D. J., Ho, S. C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K. C., & Bluestone, J. A. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1145 · Cited by 583
Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
Linsley, P. S., Greene, J. L., Tan, P., Bradshaw, J., Ledbetter, J. A., Anasetti, C., & Damle, N. K. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1595 · Cited by 581
Ranheim, E. A., & Kipps, T. J. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.925 · Cited by 580
Freeman, G. J., Boussiotis, V. A., Anumanthan, A., Bernstein, G. M., Ke, X.-Y., Rennert, P. D., Gray, G. S., Grlbben, J. G., & Nadler, L. M. (1995) · Immunity · doi:10.1016/1074-7613(95)90032-2 · Cited by 561
Self-citationCD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast Kinetics
van der Merwe, P. A., Bodian, D. L., Daenke, S., Linsley, P., & Davis, S. J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.393 · Cited by 551
Kawai, C. (1999) · Circulation · doi:10.1161/01.cir.99.8.1091 · Cited by 552
Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation.
Gimmi, C. D., Freeman, G. J., Gribben, J. G., Gray, G., & Nadler, L. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6586 · Cited by 548
Self-citationBorriello, F., Sethna, M. P., Boyd, S. D., Schweitzer, A. N., Tivol, E. A., Jacoby, D., Strom, T. B., Simpson, E. M., Freeman, G. J., & Sharpe, A. H. (1997) · Immunity · doi:10.1016/s1074-7613(00)80333-7 · Cited by 498
Self-citationTumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity.
Chen, L., McGowan, P., Ashe, S., Johnston, J., Li, Y., Hellström, I., & Hellström, K. E. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.523 · Cited by 462
Tan, P., Anasetti, C., Hansen, J. A., Melrose, J., Brunvand, M., Bradshaw, J., Ledbetter, J. A., & Linsley, P. S. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.1.165 · Cited by 461
Gimmi, C. D., Freeman, G. J., Gribben, J. G., Sugita, K., Freedman, A. S., Morimoto, C., & Nadler, L. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6575 · Cited by 427
Self-citationCD40 ligand-transduced co-stimulation of T cells in the development of helper function
Essen, D. V., Kikutani, H., & Gray, D. (1995) · Nature · doi:10.1038/378620a0 · Cited by 409
Interleukin‐10 inhibits B7 and intercellular adhesion molecule‐1 expression on human monocytes
Willems, F., Marchant, A., Delville, J., Gérard, C., Delvaux, A., Velu, T., De Boer, M., & Goldman, M. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240435 · Cited by 376
CD28, CTLA‐4 and their ligands: who does what and to whom?
Sansom, D. M. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00121.x · Cited by 362
Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity
Guinan, E., Gribben, J., Boussiotis, V., Freeman, G., & Nadler, L. (1994) · Blood · doi:10.1182/blood.v84.10.3261.3261 · Cited by 358
Self-citationSharpe, A. H. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00784.x · Cited by 357
Freeman, G. J., Borriello, F., Hodes, R. J., Reiser, H., Gribben, J. G., Ng, J. W., Kim, J., Goldberg, J. M., Hathcock, K., & Laszlo, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2185 · Cited by 351
Self-citationCD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator
Cai, G., Anumanthan, A., Brown, J. A., Greenfield, E. A., Zhu, B., & Freeman, G. J. (2008) · Nature Immunology · doi:10.1038/ni1554 · Cited by 345
Self-citationFreeman, G. J., Gray, G. S., Gimmi, C. D., Lombard, D. B., Zhou, L. J., White, M., Fingeroth, J. D., Gribben, J. G., & Nadler, L. M. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.625 · Cited by 344
Self-citationThe B7 Family and Cancer Therapy: Costimulation and Coinhibition
Zang, X., & Allison, J. P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1030 · Cited by 336
Xiao, Y., Yu, S., Zhu, B., Bedoret, D., Bu, X., Francisco, L. M., Hua, P., Duke-Cohan, J. S., Umetsu, D. T., Sharpe, A. H., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20130790 · Cited by 321
Self-citationThe CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.
Koulova, L., Clark, E. A., Shu, G., & Dupont, B. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.759 · Cited by 321
Azuma, M., Cayabyab, M., Buck, D., Phillips, J. H., & Lanier, L. L. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.2.353 · Cited by 318
Costimulation of T cells for tumor immunity
Chen, L., Linsley, P. S., & Hellström, K. E. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90262-j · Cited by 315
Freedman, A. S., Freeman, G. J., Rhynhart, K., & Nadler, L. M. (1991) · Cellular Immunology · doi:10.1016/0008-8749(91)90091-o · Cited by 312
Self-citationFunctional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations.
Larsen, C. P., Ritchie, S. C., Pearson, T. C., Linsley, P. S., & Lowry, R. P. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.4.1215 · Cited by 302
The role of B7 co‐stimulation in activation and differentiation ofCD4+and CD8+T cells
Mc Adam, A. J., Schweitzer, A. N., & Sharpe, A. H. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01242.x · Cited by 301
Lam, B. K., Penrose, J. F., Freeman, G. J., & Austen, K. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7663 · Cited by 296
Self-citationRincón, M., & Flavell, R. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06757.x · Cited by 289
Arlen, P. M., Gulley, J. L., Parker, C., Skarupa, L., Pazdur, M., Panicali, D., Beetham, P., Tsang, K. Y., Grosenbach, D. W., Feldman, J., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2059 · Cited by 287
Costimulatory and coinhibitory receptors in anti‐tumor immunity
Driessens, G., Kline, J., & Gajewski, T. F. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00771.x · Cited by 286
An Enigmatic Tail of CD28 Signaling
Boomer, J. S., & Green, J. M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002436 · Cited by 283
“Although CD28 and CTLA-4 both bind the ligands B7-1 (CD80) and B7-2 (CD86) (Freeman et al. 1989; Balzano et al. 1992; Azuma et al. 1993; Freeman et al. 1993) and are located on human chromosome 2q33 (Naluai et al. 2000) (mouse chromosome 1 (Gross et al. 1990; Howard et al. 1991)), CTLA-4 forms bivalent homodimers betw…”
BackgroundInfluentialHuman CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation.
Hall, K. T., Boumsell, L., Schultze, J. L., Boussiotis, V. A., Dorfman, D. M., Cardoso, A. A., Bensussan, A., Nadler, L. M., & Freeman, G. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11780 · Cited by 267
Self-citationFunctional expression of B7/BB1 on activated T lymphocytes.
Azuma, M., Yssel, H., Phillips, J. H., Spits, H., & Lanier, L. L. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.3.845 · Cited by 267
Young, J. W., Koulova, L., Soergel, S. A., Clark, E. A., Steinman, R. M., & Dupont, B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115840 · Cited by 265
Local Delivery of Ox40l , Cd80 , and Cd86 mRNA Kindles Global Anticancer Immunity
Haabeth, O. A. W., Blake, T. R., McKinlay, C. J., Tveita, A. A., Sallets, A., Waymouth, R. M., Wender, P. A., & Levy, R. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2867 · Cited by 129
Metadata
- Authors
- Freeman, G. J., Freedman, A. S., Segil, J. M., Lee, G., Whitman, J. F., & Nadler, L. M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1989-10
- Volume
- 143
- Issue
- 8
- Pages
- 2714-2722
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1734926275
- Cited by
- 476
- References
- 0
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.